[{"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0711-2023", "product_description": "oxyTOCIN 60 units added to 0.9% sodium chloride 1,000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-6045-1.", "product_quantity": "1332 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-883073, Exp 04/28/2023; 37-887776, Exp 05/17/2023; 37-889209, Exp 05/23/2023; 37-892588, Exp 06/06/2023; 37-894449, Exp 06/13/2023; 37-898552, Exp 06/29/2023"}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "92892", "recalling_firm": "APG SEVEN, INC", "address_1": "12030 Sw 129th Ct Ste 205", "address_2": "N/A", "postal_code": "33186-4584", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1150-2023", "product_description": "Vegetal Vigra, 200mg capsules, 8-count bottle, Manufacturer: Hand-shaking (Int'l) Corp. USA ADD: Hand-shaking Mansion, the 5th Ave., Stanford, USA. UPC 8 931028 556885", "product_quantity": "120 bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.", "recall_initiation_date": "20230803", "center_classification_date": "20230915", "report_date": "20230906", "code_info": "All lots, Expires: 01/31/2025"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1034-2023", "product_description": "CARDIOPLEGIA SOLUTION, 70 mEq K, Induction 8:1, non-enriched, High Potassium, IV Bag,  Total Volume = 300 mL, RX only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0214-1", "product_quantity": "148 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-253954, Exp. 7/20/2023; 36-256032, Exp. 7/28/2023"}, {"status": "Terminated", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "92848", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "N/A", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the US", "recall_number": "D-1094-2023", "product_description": "Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC: 71384-311-05.", "product_quantity": "2,683 bottles", "reason_for_recall": "Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.", "recall_initiation_date": "20230810", "center_classification_date": "20230821", "termination_date": "20240122", "report_date": "20230830", "code_info": "Lot #s: 22DEC047 exp 9/16/23, 23FEB057 exp 11/24/23."}, {"status": "Ongoing", "city": "Lenoir", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93265", "recalling_firm": "Exela Pharma Sciences LLC", "address_1": "1245 Blowing Rock Blvd", "address_2": "N/A", "postal_code": "28645-3618", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0117-2024", "product_description": "Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL (1mg/mL), 100 mL Single-Dose Vial, 25 count carton, Ready to Use For Intravenous Infusion Only Preservative Free, Rx Only, Manufactured and Distributed by Exela Pharma Sciences, LLC, Lenoir, NC 28645, (Vial NDC 51754-2131-1; Carton NDC 51754-2131-4).", "product_quantity": "23,425 vials", "reason_for_recall": "Presence of Particulate Matter: Silicone", "recall_initiation_date": "20231018", "center_classification_date": "20231122", "report_date": "20231129", "code_info": "Lot # 10001088 exp 07/31/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0804-2023", "product_description": "Fluticasone Propionate Nasal Spray, 50mcg, 16 g bottles, Manufactured by: HI-TECH PHARMACAL CO., INC., Amiy.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91980", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "RemedyRepack distributed product to consignees nationwide within the United States", "recall_number": "D-0490-2023", "product_description": "Aripiprazole 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2921-03", "product_quantity": "3 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20230320", "center_classification_date": "20230331", "termination_date": "20231019", "report_date": "20230412", "code_info": "Lot #: J0620431-052322, Exp. Date 05/31/23", "more_code_info": ""}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0273-2023", "product_description": "Amikacin 450MG IN NS 45ML, Antibiotic, used in a HOMEPUMP, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300 Chesapeake, VA 23320,", "product_quantity": "7 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use date: December 28 - December 30, 2022"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0806-2023", "product_description": "Granisetron HCl Injection, USP, 1 mg/mL, packaged in a) 1mL and b) 4 mL vials, Rx Only, For Intravenous Use Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0828-2023", "product_description": "Midazolam Injection, USP 2mg/2mL (1 mg/mL) For Intramuscular or Intravenous Use Only, 2mL vials, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091643"], "brand_name": ["FINASTERIDE"], "generic_name": ["FINASTERIDE"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-089"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FINASTERIDE"], "rxcui": ["200172"], "spl_id": ["2397604d-3fd8-2d97-e063-6394a90a0750"], "spl_set_id": ["e3728709-e805-4b46-9954-2c433a865987"], "package_ndc": ["16729-089-10", "16729-089-15"], "is_original_packager": [true], "upc": ["0316729089104", "316729089104", "316729089159"], "nui": ["N0000175836", "N0000000126"], "pharm_class_epc": ["5-alpha Reductase Inhibitor [EPC]"], "pharm_class_moa": ["5-alpha Reductase Inhibitors [MoA]"], "unii": ["57GNO57U7G"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0390-2023", "product_description": "Finasteride Tablets USP, 1 mg, Rx Only, Packaged as:  a) 30-count bottle NDC 16729-089-10 UPC 3 16729 08910 4; b) 90-count bottle NDC 16729-089-15 UPC 3 16729 08915 9; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA", "product_quantity": "325,356 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) P2005979, Exp. Date 10/31/2023; P2100252, Exp. Date 12/31/2023; P2101710, Exp. Date 2/29/2024;  b) P2100253, Exp. Date 12/31/2023;  P2103035, Exp. Date 4/30/2024; P2103036, Exp. Date 4/30/2024;", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0955-2023", "product_description": "vancomycin 1.25 g/250 mL added to 0.9% Sodium Chloride, 5 mg/mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6074-1", "product_quantity": "15,304  bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-254431, Exp. 9/5/2023; 36-255125, 36-255126, 36-255127, Exp. 9/6/2023; 36-248083 Exp. 8/10/2023; 36-238973, 36-238980, Exp. 7/10/2023; 36-239520, Exp. 7/12/2023; 36-240087, Exp. 7/13/2023; 36-248979, 36-248980, 36-248981, Exp. 8/16/2023; 36-240760, 36-240761, 36-240762, Exp. 7/17/2023; 36-240837, 36-240838, Exp. 7/18/2023; 36-241131, 36-241132, Exp. 7/19/2023; 36-241436, Exp. 7/20/2023; 36-251065, Exp. 8/24/2023; 36-241980, Exp. 7/24/2023; 36-242707, Exp. 7/26/2023; 36-243153, 36-243155, 36-243156, Exp. 7/27/2023; 36-252188, 36-252189, 36-252191, 36-252192, 36-252198, 36-252201, Exp. 8/31/2023; 36-243951, Exp. 7/31/2023."}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA211884"], "brand_name": ["SUCRALFATE"], "generic_name": ["SUCRALFATE"], "manufacturer_name": ["VistaPharm, LLC"], "product_ndc": ["66689-305"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SUCRALFATE"], "rxcui": ["313123"], "spl_id": ["f133ac10-0969-47cb-932a-7b100b05105c"], "spl_set_id": ["cbfbe146-5d42-4a55-9050-df2b5581487a"], "package_ndc": ["66689-305-16"], "is_original_packager": [true], "upc": ["0366689305165"], "nui": ["N0000175801", "M0015420"], "pharm_class_epc": ["Aluminum Complex [EPC]"], "pharm_class_cs": ["Organometallic Compounds [CS]"], "unii": ["XX73205DH5"]}, "product_type": "Drugs", "event_id": "93096", "recalling_firm": "VistaPharm LLC", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0047-2024", "product_description": "Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771 USA, NDC 66689-305-16", "product_quantity": "180 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.", "recall_initiation_date": "20231018", "center_classification_date": "20231016", "termination_date": "20240430", "report_date": "20231025", "code_info": "Lot#: 810300, Exp 10/2023"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA211980"], "brand_name": ["NOREPINEPHRINE BITARTRATE"], "generic_name": ["NOREPINEPHRINE BITARTRATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-615"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NOREPINEPHRINE BITARTRATE"], "rxcui": ["242969"], "spl_id": ["4bb42f07-a41e-42f3-92e7-dab665584f84"], "spl_set_id": ["4bb42f07-a41e-42f3-92e7-dab665584f84"], "package_ndc": ["47335-615-44", "47335-615-40"], "is_original_packager": [true], "unii": ["IFY5PE3ZRW"]}, "product_type": "Drugs", "event_id": "91983", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "N/A", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0529-2023", "product_description": "Norepinephrine Bitartrate Injection, USP, 4 mg/4 mL* (1 mg/mL), 4 mL Single-dose Fliptop Vial (NDC 47335-615-40); packaged in 10 x 4 mL Single-dose Fliptop Vials per carton (NDC 47335-615-44); Rx only, Manufactured by: Gland Pharma Limited, Hyderabad-502307 India; Distributed by: Sun Phamaceutical Industries, Inc., Cranbury, NJ 08512.", "product_quantity": "16,450 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: Above the specification limits yielded for related substance norepinephrine sulfonic acid impurity during routine product monitoring.", "recall_initiation_date": "20230329", "center_classification_date": "20230410", "termination_date": "20231031", "report_date": "20230419", "code_info": "Lot Number: G1510001, Exp 11/2023; G151002, Exp. 12/2023; and G151003, Exp 02/2024"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91749", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0361-2023", "product_description": "Phenylephrine HCl Injection, USP, 0.8 mg/10 mL (80 mcg/mL), 10 mL Single-Dose Vial, packaged in 30 x 10 mL Single-Dose Vials per carton, 12 x 30 Vials Carton per case, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-301-10.", "product_quantity": "24,870 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230222", "center_classification_date": "20230227", "termination_date": "20240924", "report_date": "20230308", "code_info": "Lots: PE2029, Exp. 06/17/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Rosenberg", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92164", "recalling_firm": "Seatex LLC", "address_1": "445 Highway 36 N", "address_2": "", "postal_code": "77471-8756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, TX", "recall_number": "D-0562-2023", "product_description": "Seatex Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-Sterile Solution Net Contents: 3.785 L (1 Gallon) Container, UPC 6 12592 01480 0 Seatex, LLC. 445 TX Hwy 36 Rosenberg, TX 77471.", "product_quantity": "2880 containers", "reason_for_recall": "Superpotent Drug and Failed Impurities/Degradation Products: formula does not adhere to the labeled specifications", "recall_initiation_date": "20230419", "center_classification_date": "20230503", "report_date": "20230510", "code_info": "Lot: 220888, Exp. 05/20/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92248", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0566-2023", "product_description": "Advil Liqui-Gels Solubilized Ibuprofen Capsules, 200 mg Pain Reliever/Fever Reducer (NSAID) a) 20-count Liquid Filled Capsule bottles; b) 40-count Liquid Filled Capsule bottles.", "product_quantity": "Pending", "reason_for_recall": "CGMP deviation: product outside labeled storage temperature requirements.", "recall_initiation_date": "20230331", "center_classification_date": "20230504", "report_date": "20230510", "code_info": "SKUs a) 0999841; b) 0916071 stored and distributed from DCs 07/28/2022 through 03/31/2023.", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0822-2023", "product_description": "Lidocaine Ointment USP, 5%, 1 1/4 oz tubes, Rx Only, Manufactured for: HI-TECH PHARMACAL CO., INC., Amityville, NY 11701.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0212-2023", "product_description": "GLYCERIN STERILE 99% 2ML VIAL and 5ML VIAL, Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221004@24 t20221115@20 t20221116@36", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0726-2023", "product_description": "heparin added to 0.9% sodium chloride, 7,500 units/1,000 mL* (7.5 units/mL), 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-7009-1.", "product_quantity": "3055 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-888668, 37-888685, 37-888701, Exp 05/02/2023; 37-890550, 37-890556, Exp 05/09/2023; 37-892201, 37-892216, Exp 05/16/2023; 37-893866, 37-893917, 37-893918, Exp 05/23/2023; 37-895705, 37-895717, Exp 05/30/2023"}, {"status": "Ongoing", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93257", "recalling_firm": "Botanical Be", "address_1": "360 Jardin Bello", "address_2": "", "postal_code": "79932-2357", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA Nationwide", "recall_number": "D-0226-2024", "product_description": "Kuka Flex Forte caplets, packaged in 30-count bottles, Manufactured by: Kukamonga, Gonzalez Ortega No 170 Col Centro, 44100 Guadalajara Jal, UPC 0736640810265", "product_quantity": "300 bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.", "recall_initiation_date": "20231020", "center_classification_date": "20240112", "report_date": "20231206", "code_info": "All lots, exp 12/12/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0859-2023", "product_description": "Midazolam Injection, USP, 50 mg/10mL (5mg/mL), For Intramuscular or Intravenous Use Only, 10 mL vials, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0681-2023", "product_description": "Modified del Nido Microplegia, packaged in 40 mL per syringe, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0219-1.", "product_quantity": "690 syringes", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-893821, Exp 04/28/2023; 37-894813, 37-894815, Exp 04/30/2023; 37-895489, 37-895490, Exp 05/05/2023; 37-897810, 37-897811, Exp 05/13/2023; 37-899585, Exp 05/20/2023"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1023-2023", "product_description": "CARDIOPLEGIA SOLUTION, 7.5 mEq K, Reperfusate 4:1, low potassium, IV Bag,  total volume = 238.75 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0007-1", "product_quantity": "56 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-252143, Exp. 7/20/2023."}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0713-2023", "product_description": "dilTIAZem added to 0.9% sodium chloride, 125 mg/125 mL* (1 mg/mL), 125 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-6055-1.", "product_quantity": "3040 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-896374, 37-896375, Exp 05/31/2023; 37-896876, 37-896878, Exp 06/02/2023; 37-897077, 37-897078, Exp 06/05/2023; 37-900074, 37-900075, 37-900076, 37-900111, 37-900112, 37-900115, Exp 06/15/2023; 37-900328, Exp 06/16/2023"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0733-2023", "product_description": "PHENYLephrine added to 0.9% sodium chloride, 20 mg/250 mL* (80 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-7025-1.", "product_quantity": "13953 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-883074, Exp 04/28/2023; 37-883237, 37-883238, Exp 04/30/2023; 37-883940, Exp 05/02/2023; 37-884271, Exp 05/03/2023; 37-884749, 37-884751, Exp 05/05/2023; 37-885338, Exp 05/08/2023; 37-885756, Exp 05/09/2023; 37-886272, Exp 05/11/2023; 37-887512, Exp 05/16/2023; 37-888027, 37-888030, 37-888040, 37-888052, 37-888063, Exp 05/18/2023; 37-888314, Exp 05/21/2023; 37-890489, 37-890497, 37-890534, Exp 05/29/2023; 37-890933, Exp 05/30/2023; 37-891152, Exp 05/31/2023; 37-892985, 37-892986, 37-892995, Exp 06/07/2023; 37-893511, 37-893517, Exp 06/11/2023; 37-896481, Exp 06/21/2023; 37-897828, Exp 06/27/2023; 37-898523, Exp 06/29/2023"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207068"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-008", "16729-009", "16729-010", "16729-011"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["0e03244d-61de-bb5f-e063-6294a90a671c"], "spl_set_id": ["6c011348-a236-47d3-bbef-3e0b956dd080"], "package_ndc": ["16729-008-15", "16729-008-16", "16729-008-17", "16729-009-15", "16729-009-16", "16729-009-17", "16729-010-15", "16729-010-16", "16729-010-17", "16729-011-15", "16729-011-16", "16729-011-17"], "is_original_packager": [true], "unii": ["3M8608UQ61"], "upc": ["316729008150", "316729008167"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0421-2023", "product_description": "Pravastatin Sodium Tablets USP, 10 mg, Rx Only, Packaged as: a) 90-count bottle NDC 16729-008-15, UPC 3 16729 00815 0; b) 500-count bottle NDC 16729-008-16, UPC 3 16729 00816 7; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA", "product_quantity": "9600 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) R2201093, Exp. Date 4/30/2024; b) R2201222, R2201231, Exp. Date 4/30/2024;", "more_code_info": ""}, {"status": "Terminated", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M015"], "brand_name": ["DIBUCAINE"], "generic_name": ["DIBUCAINE"], "manufacturer_name": ["Akron Pharma Inc."], "product_ndc": ["71399-2829"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["DIBUCAINE"], "rxcui": ["238784"], "spl_id": ["da90939a-75f0-4b82-94ff-8611fe746715"], "spl_set_id": ["60469e43-ab6f-46d3-a1df-00e58275f565"], "package_ndc": ["71399-2829-1", "71399-2829-2"], "is_original_packager": [true], "nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_cs": ["Allergens [CS]"], "unii": ["L6JW2TJG99"]}, "product_type": "Drugs", "event_id": "91785", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0454-2023", "product_description": "DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC 71399-2829-1", "product_quantity": "4,416 tubes", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20230217", "center_classification_date": "20230309", "termination_date": "20240909", "report_date": "20230315", "code_info": "Lot #: 2206016, Exp. date 05/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207068"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-008", "16729-009", "16729-010", "16729-011"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["0e03244d-61de-bb5f-e063-6294a90a671c"], "spl_set_id": ["6c011348-a236-47d3-bbef-3e0b956dd080"], "package_ndc": ["16729-008-15", "16729-008-16", "16729-008-17", "16729-009-15", "16729-009-16", "16729-009-17", "16729-010-15", "16729-010-16", "16729-010-17", "16729-011-15", "16729-011-16", "16729-011-17"], "is_original_packager": [true], "unii": ["3M8608UQ61"], "upc": ["316729009157"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0422-2023", "product_description": "Pravastatin Sodium Tablets USP 20 mg, Rx Only, 90-count bottle, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA. NDC 16729-009-15, UPC 3 16729 00915 7.", "product_quantity": "32,688 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a )R2200589, R2200689, R2200690, R2201232, Exp. Date 4/30/2024", "more_code_info": ""}, {"status": "Completed", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078287"], "brand_name": ["ONDANSETRON HYDROCHLORIDE"], "generic_name": ["ONDANSETRON HYDROCHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["36000-012", "36000-013"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["ONDANSETRON HYDROCHLORIDE"], "rxcui": ["283504", "1740467"], "spl_id": ["f917f6a4-bb84-46ed-ba13-68e4c01097e6"], "spl_set_id": ["729d865f-d84a-495e-9456-4bceebb6e03f"], "package_ndc": ["36000-012-25", "36000-013-01"], "is_original_packager": [true], "upc": ["0336000012256"], "unii": ["NMH84OZK2B"]}, "product_type": "Drugs", "event_id": "93359", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0146-2024", "product_description": "Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015 USA.  Manufactured by: Baxter Pharmaceuticals India Private Ltd, Ahmedabad 382213, India. NDC 36000-012-25", "product_quantity": "6,022,675 vials", "reason_for_recall": "Failed pH Specifications", "recall_initiation_date": "20231114", "center_classification_date": "20231207", "report_date": "20231213", "code_info": "Lot # A0E0959A, A0E0961A, A0E1015A, A0E1020A, Exp. Date 30-Nov-23; A0F0016A, Exp. Date 31-Dec-23; A0F0260A, A0F0261A, A0F0262A, Exp. Date 29-Feb-24; A0F0414A, A0F0415A, A0F0416A, A0F0417A, A0F0418A, Exp. Date 30-Apr-24; A0F0503A, Exp. Date 31-May-24,  A0F0533A, A0F0534A, A0F0535A, A0F0536A, A0F0537A, A0F0540A, A0F0541A, Exp. Date 30-Jun-24; A0F0573A, A0F0574A, A0F0575A, A0F0592A, Exp. Date 31-Jul-24; A0F0596A, A0F0599A, Exp. Date 31-Aug-24 ; A0F0676A, 31-Oct-24.", "more_code_info": ""}, {"status": "Terminated", "city": "Norwalk", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91719", "recalling_firm": "Ecometics, Inc.", "address_1": "19 Concord St", "address_2": "", "postal_code": "06854-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0450-2023", "product_description": "Nose Better Gel (0.75% Camphor, 0.50% Menthol, 0.50% Allantoin), packaged in 0.46 oz. (13g) metal tubes,  Distributed by: Oakhurst Company Levittown, NY 11756", "product_quantity": "37,968 metal tube/folding carton", "reason_for_recall": "CGMP DEVIATIONS", "recall_initiation_date": "20230224", "center_classification_date": "20230308", "termination_date": "20230621", "report_date": "20230315", "code_info": "Lot #: 1E253A, Exp. Date AUG-2024", "more_code_info": ""}, {"status": "Terminated", "city": "Xiamen", "state": "N/A", "country": "China", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "91410", "recalling_firm": "GFA Production Xiamen Co. Ltd.", "address_1": "Huli Industrial Park No. 20", "address_2": "Meixi Road; Tong'An", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and Canada.", "recall_number": "D-0244-2023", "product_description": "Easy Care first aid Burn Cream (benzalkonium chloride 0.13% and lidocaine hydrochloride 0.5%), 0.9 g (0.03 oz) packets packaged in boxes of 10, Treatment for Burns, Made in China for Adventure Ready Brands, 944 Industrial Park Rd., Littleton, NH 03561, NDC 90107-0210, Product # 9999-1515", "product_quantity": "2880 packets", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.", "recall_initiation_date": "20221223", "center_classification_date": "20230127", "termination_date": "20250729", "report_date": "20230208", "code_info": "Lot # W06I28, exp 09/28/2024"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93187", "recalling_firm": "Dollar Tree Distribution, Inc.", "address_1": "500 Volvo Pkwy", "address_2": "N/A", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0045-2024", "product_description": "Certain Over-The-Counter (OTC) drug products sold by Family Dollar retail stores.", "product_quantity": "4,261,383 units of various products", "reason_for_recall": "CGMP Deviations: OTC products were stored outside of labeled temperature requirements.", "recall_initiation_date": "20231005", "center_classification_date": "20231016", "report_date": "20231025", "code_info": "Certain drug products sold by Family Dollar retail stores located in AL, AR, AZ, CA, CO, FL, GA, ID, KS, LA, MS, MT, ND, NE, NM, NV, OK, OR, SD, TX, UT, WA, and WY."}, {"status": "Ongoing", "city": "Schaumburg", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92376", "recalling_firm": "Sagent Pharmaceuticals Inc", "address_1": "1901 N Roselle Rd Ste 450", "address_2": "N/A", "postal_code": "60195-3194", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0762-2023", "product_description": "Nafcillin for Injection, USP, 1 gram per vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195.  NDC:  25021-139-10", "product_quantity": "2,249,980 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230519", "center_classification_date": "20230523", "report_date": "20230531", "code_info": "Lot: NFG101, EXP: 1/31/2024; Lot: NFG102, EXP: 9/30/2024; Lot: NFG201, 5/31/2025"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91980", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "RemedyRepack distributed product to consignees nationwide within the United States", "recall_number": "D-0501-2023", "product_description": "Rosuvastatin 10mg tablets, packaged in a) 30-count bottles (NDC 70518-0375-03 and 70518-0375-01) and b) 90-count bottles (NDC 70518-0375-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.", "product_quantity": "a) 399 bottles, b)445 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20230320", "center_classification_date": "20230331", "termination_date": "20231019", "report_date": "20230412", "code_info": "Lot#: a) NDC 70518-0375-03: J0674788-011123, Exp. Date 01/31/2024; J0664118-112922 J0664118-112922, Exp. Date 12/31/2023; J0653727-101722, Exp. Date 10/31/2023. NDC 70518-0375-01: B2057931-011223, Exp. Date 07/31/2025  b) Lot #: B2075815-012523, Exp. Date 09/30/2025; B2011634-121322, Exp. Date 07/31/2025 B1970205-112022, Exp. Date 06/30/2024; B1862598-092022, Exp. Date 03/31/2024; B2077226-012523, B2070444-012023, Exp. Date 07/31/2025.", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212971"], "brand_name": ["KIRKLAND SIGNATURE ALLER FEX"], "generic_name": ["FEXOFENADINE HYDROCHLORIDE"], "manufacturer_name": ["Costco Wholesale Company"], "product_ndc": ["63981-847"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE"], "rxcui": ["997420"], "spl_id": ["9d7724ba-f3b3-4ac8-9558-42753f6fe838"], "spl_set_id": ["651d14d1-c5de-4cb9-9484-b05986e641ac"], "package_ndc": ["63981-847-48"], "is_original_packager": [true], "unii": ["2S068B75ZU"]}, "product_type": "Drugs", "event_id": "91672", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0905-2023", "product_description": "Allergy ALLER-FEX, Fexofenadine Hydrochloride Tablets, 180 mg, 180-count cartons, Packaged by: Perrigo, 515 Eastern Ave., Allegan, MI 49010 USA. NDC 63981-847-48", "product_quantity": "360,184", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230209", "center_classification_date": "20230711", "termination_date": "20230911", "report_date": "20230719", "code_info": "Lot #: 2DV1487, 2DV1870, 2DV1871, 2DV1873, 2EV1676, 2GV2132, 2HV2679, Exp. date 12/23; 2DV2000, exp. date 11/23; 2LV1573, 2MV1314, Exp. date 04/24; 2FV1764, 2FV1765  2FV1766, 2GV1579, 2GV1937, 2GV1941 , 2GV1942, 2GV2157, 2HV1886, 2HV1997, 2HV2019,  2HV2047, Exp. datev02/24; 2EV1666, 2EV1667, 2EV1668, 2EV1670, 2EV1671, 2EV1672,  2EV1674, 2EV1677, 2EV1678, 2HV2017, Exp. date 01/24.", "more_code_info": ""}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0298-2023", "product_description": "INTRALIPID 18GM, TPN, Rx Only, use with a Curlin pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,", "product_quantity": "7 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 29-30, 2022"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "92073", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0555-2023", "product_description": "Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor, CT 06095, NDC# 70004-085-44", "product_quantity": "73,312 containers", "reason_for_recall": "Subpotent Drug: Out of specification results for low potency was obtained.", "recall_initiation_date": "20230410", "center_classification_date": "20230427", "termination_date": "20230920", "report_date": "20230503", "code_info": "Lot #  1222043028 04/11/23 1222043029 04/13/23  1222043031 04/12/23  1222043032 04/12/23  1222043033 04/13/23  1222043034 04/13/23  1222043035 04/14/23  1222043036 04/14/23  1222043037 04/18/23 1222043038 04/18/23  1222043039 04/19/23  1222043040 04/19/23  1222043041 04/20/23  1222043042 04/20/23  1222043043 04/21/23  1222043044 04/21/23  1223041990 05/03/23  1223041991 05/03/23  1223041992 05/05/23  1223041993 05/06/23  1223041996 05/11/23  1223041997 05/10/23  1223041998 05/11/23  1223041999 05/12/23  1223042000 05/12/23  1223042001 05/13/23  1223042002 05/16/23  1223042003 05/17/23 1223042004 05/21/23 1223042006 05/16/23  1223042007 05/06/23  1223042008 05/10/23  1223042009 05/05/23  1223042010 05/04/23  1223042766 05/18/23  1223042767 05/17/23  1223042769 05/18/23  1223042770 05/19/23  1223042771 05/19/23  1223042772 05/20/23  1223042773 05/21/23  1223042774 05/23/23  1223042776 05/23/23  1223042777 05/24/23  1223042778 05/24/23  1223042783 05/31/23 1223042784 06/01/23  1223042785 05/31/23  1223042786 06/01/23  1223044081 06/02/23  1223044082 06/02/23  1223044117 06/06/23  1223044118 06/06/23  1223044143 06/03/23 1223044144 06/03/23  1223044166 06/14/23  1223044173 06/07/23  1223044191 06/07/23 1223044198 06/08/23  1223044220 06/08/23  1223044225 06/13/23  1223044247 06/14/23  1223044255 06/14/23  1223044267 06/15/23  1223044302 06/15/23  1223044311 06/16/23  1223044389 06/24/23  1223044523 06/24/23  1223044552 06/28/23  1223044582 06/27/23  1223044590 06/27/23  1223044629 06/29/23  1223044636 06/29/23  1223044656 06/30/23  1223044662 06/30/23  1223044682 07/01/23  1223044687 07/01/23  1223044711 07/05/23  1223044741 07/04/23  1223044749 07/04/23  1223044774 07/05/23  1223044793 07/06/23  1223044868 07/08/23"}, {"status": "Ongoing", "city": "East Hanover", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA050573"], "brand_name": ["SANDIMMUNE"], "generic_name": ["CYCLOSPORINE"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "product_ndc": ["0078-0109", "0078-0240", "0078-0241", "0078-0110"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CYCLOSPORINE"], "rxcui": ["197552", "197553", "205175", "212810", "212844", "212957", "309632", "328160"], "spl_id": ["0b1732c5-125d-4878-867d-b4b9d6d2c50e"], "spl_set_id": ["5e5926a7-1de0-4b54-a5c0-286b6200ff82"], "package_ndc": ["0078-0240-61", "0078-0240-15", "0078-0241-61", "0078-0241-15", "0078-0109-61", "0078-0109-01", "0078-0110-22"], "is_original_packager": [true], "nui": ["N0000175457", "N0000175458", "N0000182141", "N0000185503"], "pharm_class_epc": ["Calcineurin Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Calcineurin Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["83HN0GTJ6D"]}, "product_type": "Drugs", "event_id": "93464", "recalling_firm": "Novartis Pharmaceuticals Corporation", "address_1": "1 Health Plz", "address_2": "", "postal_code": "07936-1016", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0144-2024", "product_description": "SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936. NDC 0078-0110-22", "product_quantity": "6,997 bottles", "reason_for_recall": "Crystallization:  bottles of Sandimmune Oral Solution were determined to contain crystals", "recall_initiation_date": "20231122", "center_classification_date": "20231207", "report_date": "20231213", "code_info": "Lot #: FX001500, FX001582, Exp. 09/30/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91757", "recalling_firm": "Teva Pharmaceuticals USA Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A.", "recall_number": "D-0469-2023", "product_description": "Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%, Antihistamine, 2.5 mL (0.085 fl oz) bottle, Sterile, Distributed by Medtech Products Inc. Tarrytown, NY 10591, A Prestige Consumer Healthcare company, Made in Israel, UPC 678112000708; NDC 67172-504-01.", "product_quantity": "715,632 bottles", "reason_for_recall": "Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.", "recall_initiation_date": "20230223", "center_classification_date": "20230320", "termination_date": "20231128", "report_date": "20230322", "code_info": "Lot #114349, Exp. 05/2023; 117396, Exp. 09/2023; 120128, Exp. 11/2023; 114371, Exp. 06/2023; 123781, Exp. 02/2024."}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91670", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0436-2023", "product_description": "Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10), Distributed by: American Health Packaging, Columbus, Ohio 43217.  NDC Carton:  60687-493-01; NDC Unit Dose: 60687-493-11.", "product_quantity": "422 cartons", "reason_for_recall": "Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.", "recall_initiation_date": "20230127", "center_classification_date": "20230306", "termination_date": "20240512", "report_date": "20230315", "code_info": "Lot 1009065, Exp 12/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211143"], "brand_name": ["METOPROLOL SUCCINATE"], "generic_name": ["METOPROLOL SUCCINATE ER TABLETS"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-501", "68001-500", "68001-502", "68001-503"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METOPROLOL SUCCINATE"], "rxcui": ["866412", "866419", "866427", "866436"], "spl_id": ["041e82dd-5b9b-11e0-e063-6294a90aca1a"], "spl_set_id": ["6588d77c-090f-4722-9c91-437887d4624a"], "package_ndc": ["68001-500-00", "68001-500-03", "68001-500-08", "68001-501-00", "68001-501-03", "68001-501-08", "68001-502-00", "68001-502-03", "68001-502-08", "68001-503-00"], "is_original_packager": [true], "upc": ["0368001500005"], "unii": ["TH25PD4CCB"]}, "product_type": "Drugs", "event_id": "91528", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0269-2023", "product_description": "Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, packaged in (a) 100-count bottle, NDC 68001-501-00; (b) 500-count bottle, NDC 68001-501-03. Manufactured by Alkem Laboratories Ltd., India. For BluePoint Laboratories", "product_quantity": "(a) 6670 100-count (b) 2666 500-count bottles", "reason_for_recall": "Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer  which included lots that were packaged for BluePoint Laboratories.", "recall_initiation_date": "20230111", "center_classification_date": "20230215", "termination_date": "20240512", "report_date": "20230222", "code_info": "Lots: (a) 21143211, EXP 03/31/2023; (b) 21143185, 21143193, EXP 02/28/2023"}, {"status": "Terminated", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92690", "recalling_firm": "New England Life Care, Inc. dba Advanced Compounding Solutions", "address_1": "4 Constitution Way Ste L", "address_2": "N/A", "postal_code": "01801-1042", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0927-2023", "product_description": "PHENYLephrine HCl 10mg added to 0.9% Sodium Chloride 250mL, 250 mL IV Bag @60 Total volume), RX only, Advanced Compounding Solutions, 4 Constitution Way Ste L Woburn, MA 01801-1042, NDC: 71546-450-25;", "product_quantity": "82 Bags", "reason_for_recall": "CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.", "recall_initiation_date": "20230710", "center_classification_date": "20230719", "termination_date": "20231204", "report_date": "20230726", "code_info": "Lot # 20230524-6FBB77, Exp 21OCT2023", "more_code_info": ""}, {"status": "Terminated", "city": "Dunn", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93418", "recalling_firm": "Family Medical Supply Inc", "address_1": "2011 W Cumberland St", "address_2": "N/A", "postal_code": "28334-4447", "voluntary_mandated": "N/A", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0106-2024", "product_description": "Oxygen, Compressed USP, UN 1072, packaged in cylinders labeled as Size: a) C; b) D; c) E; d) H; e) M; f) M6, Rx only, Family Medical Supply, 2011 W Cumberland St. Dunn, NC 28334.", "product_quantity": "26,657 Cylinders", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20231109", "center_classification_date": "20231116", "termination_date": "20250808", "report_date": "20231122", "code_info": "All lots manufactured and distributed May 10, 2023, through October 31, 2023."}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA040302"], "brand_name": ["LIDOCAINE HYDROCHLORIDE"], "generic_name": ["LIDOCAINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1323", "0409-4903", "0409-4904", "0409-9137"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LIDOCAINE HYDROCHLORIDE"], "rxcui": ["1012066", "1012068"], "spl_id": ["b386f7fc-ec89-4d73-aba6-2019a9cb1d4a"], "spl_set_id": ["ad1ef0a8-88db-4648-c098-d009eaeb4e5b"], "package_ndc": ["0409-4903-11", "0409-4903-34", "0409-4904-11", "0409-4904-34", "0409-1323-15", "0409-1323-05", "0409-9137-11", "0409-9137-05"], "is_original_packager": [true], "unii": ["V13007Z41A"]}, "product_type": "Drugs", "event_id": "93124", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US and Puerto Rico.  The products were not distributed to government accounts or foreign consignees.", "recall_number": "D-0101-2024", "product_description": "1% Lidocaine HCl Injection, USP, 50mg/5mL(10mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4904-11", "product_quantity": "21,390 vials", "reason_for_recall": "Presence of Particulate Matter: identified as glass.", "recall_initiation_date": "20231002", "center_classification_date": "20231109", "termination_date": "20250214", "report_date": "20231115", "code_info": "Lot#: 42290DK, Exp. 6/1/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbia", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92348", "recalling_firm": "Apollo Care, LLC", "address_1": "3801 Mojave Ct Ste 101", "address_2": "N/A", "postal_code": "65202-4042", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Missouri only", "recall_number": "D-0643-2023", "product_description": "VANComycin 2.5 g added to 500 mL of 0.9% Sodium Chloride Injection, Rx Only, Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202. NDC 71170-224-50", "product_quantity": "54 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230502", "center_classification_date": "20230518", "report_date": "20230524", "code_info": "Lot #: AC-016649, Exp. Date 07/01/2023"}, {"status": "Ongoing", "city": "Redondo Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["PAIN AND FEVER"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["KinderFarms, LLC"], "product_ndc": ["82673-097"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["307668"], "spl_id": ["52688f1c-e600-4bc0-95ee-24086710e70e"], "spl_set_id": ["f33db02a-58f4-41a5-8f1f-4ec64d17f5a1"], "package_ndc": ["82673-097-04", "8500018057"], "is_original_packager": [true], "upc": ["0850001805728", "850001805728"], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "93448", "recalling_firm": "KINDER FARMS LLC", "address_1": "409 N Pacific Coast Hwy", "address_2": "", "postal_code": "90277-2870", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0142-2024", "product_description": "KinderMed KIDS' PAIN & FEVER Acetaminophen, 160 mg per 5 mL bottles, Oral Suspension, Organic Cherry Flavor, 4 FL OZ (118 mL), Distributed By: KinderFarms, Redondo Beach, CA 90277, NDC 82673-097-04, UPC 850001805728.", "product_quantity": "591,684 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20231113", "center_classification_date": "20231206", "report_date": "20231213", "code_info": "Lot: CJ70900, CJ76796, Exp: 8/2024; CJ77051, Exp: 09/2024; WK02998, WK02997, WK04390, WK02999, Exp: 10/2024; WK03716, Exp:12/2024; WK05150, WK05151, WK07174, Exp:02/2025; WK05539, WK06534, Exp: 03/2025; WK10259, WK23040, Exp: 04/2025; WK27455, Exp: 08/2025.", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212971"], "brand_name": ["EXCHANGE SELECT ALLER EASE"], "generic_name": ["FEXOFENADINE HYDROCHLORIDE"], "manufacturer_name": ["Army & Air Force Exchange Service"], "product_ndc": ["55301-847"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE"], "rxcui": ["997420"], "spl_id": ["90602f30-0627-446f-bd62-4dc80ead187d"], "spl_set_id": ["6a9597a1-f024-4497-bc52-3d5482758822"], "package_ndc": ["55301-847-39"], "is_original_packager": [true], "unii": ["2S068B75ZU"]}, "product_type": "Drugs", "event_id": "91672", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0904-2023", "product_description": "aller-ease, Fexofenadine Hydrochloride Tablets, 180 mg, 30-count cartons, Packaged For: Your Military Exchanges, By: Perrigo Company, Allegan, MI USA 49010. NDC 55301-847-39", "product_quantity": "1,920 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230209", "center_classification_date": "20230711", "termination_date": "20230911", "report_date": "20230719", "code_info": "Lot #: 2ER0285,Exp. date 01/24", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0789-2023", "product_description": "Calcipotriene Topical Solution,  0.005% (Scalp Solution), 60 mL bottles, Rx Only, Distributed by: Akorn Operating Company, LLC., Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91980", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "RemedyRepack distributed product to consignees nationwide within the United States", "recall_number": "D-0494-2023", "product_description": "Ropinirole 0.5 mg tablets, packaged in 90-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2439-00.", "product_quantity": "17 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20230320", "center_classification_date": "20230331", "termination_date": "20231019", "report_date": "20230412", "code_info": "Lot #: B1789178-080122, Exp. Date 07/31/2023; B1675475-050522, Exp. Date 05/31/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0849-2023", "product_description": "Timolol Maleate Ophthalmic Solution, USP 0.5%, packaged in a) 2.5mL bottles, b) 5mL bottles, c) 10 mL bottles, and d)15mL bottles, Rx only, Manufactured by: Akorn , Inc, Lake Forest, IL 60045. ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078866"], "brand_name": ["BUPROPION HYDROCHLORIDE"], "generic_name": ["BUPROPION HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-736", "47335-737", "47335-738"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUPROPION HYDROCHLORIDE"], "rxcui": ["993503", "993518", "993536"], "spl_id": ["b8e6ae63-c5d7-4481-b7b0-17e135670515"], "spl_set_id": ["29848192-7de3-4c0d-a822-1268dcf128b0"], "package_ndc": ["47335-736-86", "47335-736-88", "47335-736-08", "47335-736-13", "47335-737-86", "47335-737-88", "47335-737-08", "47335-737-13", "47335-738-86", "47335-738-88", "47335-738-08", "47335-738-13"], "is_original_packager": [true], "upc": ["0347335738865", "0347335737868"], "unii": ["ZG7E5POY8O"]}, "product_type": "Drugs", "event_id": "92289", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A", "recall_number": "D-0761-2023", "product_description": "buPROPrion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, 60 Tablets, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ, Manufactured by: Sun Pharmaceutical Industries Limited, Gujrat, India, NDC 47335-737-86", "product_quantity": "5,344 Bottles", "reason_for_recall": "Failed Dissolution Specifications; during stability testing", "recall_initiation_date": "20230509", "center_classification_date": "20230523", "termination_date": "20240227", "report_date": "20230531", "code_info": "Lots: HAC2240A, Exp 05/2023; HAC3162A, Exp 07/2023"}]